Bessmertny Olga, Pham Trinh
Pediatric/Hematology/Oncology/Bone Marrow Transplantation, Columbia Presbyterian Medical Center, New York, NY, USA.
Ann Pharmacother. 2002 Mar;36(3):521-5. doi: 10.1345/aph.1A098.
To provide a detailed overview of thalidomide use in pediatric patients.
English-language articles were identified through a MEDLINE search (1966-February 2001); key terms included thalidomide, child, graft-versus-host disease, cancer, HIV, Crohn's disease, Behçet's disease, and lupus erythematosus. References cited in those articles were also evaluated.
Thalidomide appears to be effective in patients with chronic, not acute, graft-versus-host disease (GVHD) and in healing aphthous ulcers in patients with HIV infection. Limited case reports suggest efficacy of thalidomide in the treatment of cutaneous manifestations of Behçet's disease, Crohn's disease, and lupus in children; however, the recurrence of disease is almost universal on drug discontinuation.
Thalidomide should be used as a last resort when all other therapies fail, preferably in male or prepubescent female patients.
详细概述沙利度胺在儿科患者中的应用情况。
通过医学文献数据库(MEDLINE,1966年 - 2001年2月)检索英文文章;关键词包括沙利度胺、儿童、移植物抗宿主病、癌症、艾滋病病毒、克罗恩病、白塞病和红斑狼疮。对这些文章中引用的参考文献也进行了评估。
沙利度胺似乎对慢性而非急性移植物抗宿主病(GVHD)患者有效,且能治愈艾滋病病毒感染患者的阿弗他溃疡。有限的病例报告表明沙利度胺对治疗儿童白塞病、克罗恩病和狼疮的皮肤表现有效;然而,停药后疾病几乎普遍复发。
当所有其他治疗方法均失败时,沙利度胺应作为最后手段使用,最好用于男性或青春期前女性患者。